Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[Primary exploration of individual biological boosting target volume for locally advanced nasopharyngeal carcinoma].

Wen G, Huang XB, Zhang WD, Lin XP, He ZC, Xia YF.

Zhonghua Yi Xue Za Zhi. 2012 Dec 4;92(45):3207-10. Chinese.

PMID:
23328468
2.

Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.

Chau RM, Teo PM, Choi PH, Cheung KY, Lee WY.

Radiother Oncol. 2001 Feb;58(2):143-53.

PMID:
11166865
3.

[Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].

Li FM, Luo W, He ZC, Zhang L, Sun Y, Qin WJ, Lu LX, Han F, Liu XQ, Liu MZ.

Ai Zheng. 2007 Oct;26(10):1127-32. Chinese.

PMID:
17927886
4.

[Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].

Zhao C, Han F, Lu LX, Huang SM, Lin CG, Deng XW, Lu TX, Cui NJ.

Ai Zheng. 2004 Nov;23(11 Suppl):1532-7. Chinese.

PMID:
15566674
6.

Radiosurgery for skull base malignancies and nasopharyngeal carcinoma.

Cmelak AJ, Cox RS, Adler JR, Fee WE Jr, Goffinet DR.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):997-1003.

PMID:
9169805
7.

[Irradiation field design according to locoregional relapse sites after radiotherapy of nasopharyngeal carcinoma].

Luo W, Tang YQ, Huang Y, Lu LX, Lu TX.

Ai Zheng. 2006 Feb;25(2):209-11. Chinese.

PMID:
16480588
8.

Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?

Chen C, Fei Z, Chen L, Bai P, Lin X, Pan J.

Med Dosim. 2014 Spring;39(1):34-7. doi: 10.1016/j.meddos.2013.09.002. Epub 2013 Oct 17.

PMID:
24140235
9.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
10.

Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.

Wang RH, Zhang SX, Zhou LH, Zhang GQ, Yu H, Lin XD, Lin S.

Biomed Mater Eng. 2014;24(1):1217-25. doi: 10.3233/BME-130923.

PMID:
24212016
11.

T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.

Jian JJ, Cheng SH, Prosnitz LR, Tsai SY, Tsai MJ, Huang AT.

Cancer. 1998 Jan 15;82(2):261-7.

PMID:
9445180
12.

A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer.

Chitapanarux I, Chomprasert K, Nobnaop W, Wanwilairat S, Tharavichitkul E, Jakrabhandu S, Onchan W, Traisathit P, Van Gestel D.

J Radiat Res. 2015 May;56(3):529-38. doi: 10.1093/jrr/rru119. Epub 2015 Feb 8.

13.

Attenuation of radiation dose by the skull base bone in patients with nasopharyngeal carcinoma: clinical importance.

Hsiung CY, Wu JM, Wang CJ, Kuo SC, Yeh SA, Hsu HC, Huang EY.

Radiology. 2001 Feb;218(2):457-63.

PMID:
11161162
14.

Reduction of radiation-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique.

Nishioka T, Shirato H, Arimoto T, Kaneko M, Kitahara T, Oomori K, Yasuda M, Fukuda S, Inuyama Y, Miyasaka K.

Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):705-12.

PMID:
9240636
15.

[Design planning target volumes (PTVs) in intensity-modulated radiotherapy for nasopharyngeal carcinoma].

Lin CG, Li GW, Lin LW, Wu YQ, Xiao DY, Zhao C, Lu TX, Cui NJ.

Ai Zheng. 2007 Feb;26(2):200-3. Chinese.

PMID:
17298753
16.

Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.

Kam MK, Chau RM, Suen J, Choi PH, Teo PM.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):145-57.

PMID:
12694833
17.

A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.

Poon I, Xia P, Weinberg V, Sultanem K, Akazawa C, Akazawa P, Verhey L, Quivey JM, Lee N.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1625-33.

PMID:
18035216
18.

[Distributions of primary nasopharyngeal carcinoma tumor and patterns of skull base erosion detected by magnetic resonance imaging].

Li YZ, Wu PH, Huang ZL, Xie CM, Zhang GY, Lu CY, Li L, Cai PQ, Liu XW.

Zhonghua Yi Xue Za Zhi. 2010 Dec 21;90(47):3347-50. Chinese.

PMID:
21223751
19.

Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.

Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH 3rd, Woo SY, Cui NJ, Butler EB.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):682-7.

PMID:
14967420
20.

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.

Teo PM, Chan AT, Lee WY, Leung TW, Johnson PJ.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):261-71.

PMID:
10030248

Supplemental Content

Support Center